Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Researchers say semaglutide may help reverse MASH, a progressive liver condition affecting millions of Americans.

Currently, there is only one U.S. government-approved treatment available for fatty liver disease, Rezdiffra (resmetirom), ...

A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

An international study led by the director of Virginia Commonwealth University’s liver institute suggests that ...

An international study led by the director of Virginia Commonwealth University’s liver institute suggests that the substance ...

A latest study has shown promising results in people suffering from metabolic dysfunction-associated steatohepatitis (MASH), ...

A major clinical trial reveals Wegovy a popular weight loss drug also treats serious liver disease MASH—reducing liver inflammation and scarring in most patients ...